Ferozsons Laboratories Limited’s financial results for the year ended June 30, 2011

Karachi: We have to inform you that the Board of Directors of our Company in their meeting held on August 27, 2011 at 12:30 P. M. at 197-A, The Mall, Rawalpindi, recommended the following;

(i) Cash Dividend

A final Cash Dividend for the year ended June 30, 2011 at Rs. 1.25 per share i.e. 12.50%. This is in addition to Interim Dividend already paid at P.s. 1.25 per share i.e. 12.50%.

(ii) Bonus Shares

It has been recommended by the Board of Directors to issue Bonus Shares in the proportion of 3 shares for every 20 shares held i.e. l5%.

Company’s Profit and Loss Account for the year ended June 30, 2011 with comparison of corresponding year is enclosed.

The Annual General Meeting of the Company will be held on September 29, 201t at 12:30 P. M. at Company’s Registered Office 197-A, The Mall, Rawalpindi.

The above entitlement will be paid to the shareholders whose name will appear in the Register of Members on September 25, 2011.

The Share Transfer Books of the Company will be closed from September 26, 2011 to October 05, 2011 (both days inclusive). Transfers received at the Office of the Company’s Share Registrar, CorpTec Associates (Pvt.) Limited, 7/3-C, Mushtaq Ahmed Gormani Road, Gulberg II, Lahore at the close of business on September 25, 2011 will be treated In time for the purpose of above entitlement to the transferees.

 

Ferozsons Laboratories Limited

Profit and Loss Account

For the year ended 30 June 2011

 

2011

2010

Note

Rupees

Rupees

Sales- net24 1,436,713,2811,273,374,822
Cost of sales25(706,369,916)(640,132,304)
 ————-————-
Gross profit 730,343,365633,242,518
Other operating income2672,582,44543,434,507
Administrative expenses27(114,700,505) (83,262,197)
Selling and distribution cost28 (325,511,125)(234,076,533)
Finance cost29(11,136,437)(5,752,880)
Other charges30(26,838,834)(28,819,846)
Share in profit of Farmacia -
98% owned partnership firm11,775,1638,007,646
————- ————-
Profit before taxation336,514,072332,773,215
Provision for taxation31(35,526,262)(15,230,540)
————-————-
Profit after taxation300,987,810317,542,675
————- ————-
Earnings per share – basic and diluted3212.0412.70

 

The annexed notes from 1 to 41 form an integral part of these financial statements.

For more information, contact:
Ferozsons Laboratories Limited
5-K.M. Sunder Raiwind Road,
Raiwind Lahore, Pakistan.
Tel: 92-42-32104001
Fax: 92-42-32101004
Email: info@ferozsons-labs.com